Phase 2, Multicenter Randomized, Double-Blind Placebo Controlled Study to Evaluate the Safety and Efficacy of EC-18 in Altering the Severity and Course of Oral Mucositis in Patients Being Treated with Concomitant Chemoradiation Therapy for Cancers

Grants and Contracts Details

StatusFinished
Effective start/end date9/13/182/26/22

Funding

  • Pharmaceutical Research Associates: $60,205.00